首页> 美国卫生研究院文献>International Journal of Endocrinology >Reduced Seminal Concentration of CD45pos Cells after Follicle-Stimulating Hormone Treatment in Selected Patients with Idiopathic Oligoasthenoteratozoospermia
【2h】

Reduced Seminal Concentration of CD45pos Cells after Follicle-Stimulating Hormone Treatment in Selected Patients with Idiopathic Oligoasthenoteratozoospermia

机译:滤泡刺激激素治疗后的特发性少精症少动精子症患者的CD45pos细胞精液浓度降低

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study evaluated the conventional sperm parameters and the seminal concentration of CD45pos cells (pan-leukocyte marker) of infertile patients with idiopathic oligoasthenoteratozoospermia (OAT). The patients were arbitrarily divided into three groups treated with recombinant follicle-stimulating hormone FSH: α (Group A = 20 patients), recombinant FSH-β (Group B = 20 patients), and highly purified human FSH (Group C = 14 patients). All treated groups achieved a similar improvement of the main sperm parameters (density, progressive motility, and morphology), but only the increase in the percentage of spermatozoa with normal morphology was significant compared to the baseline in all three examined groups. Moreover, all groups had a significant reduction of the seminal concentration of CD45pos cells and of the percentage of immature germ cells. Before and after the treatment, the concentration of CD45pos cells showed a positive linear correlation with the percentage of immature germ cells and a negative correlation with the percentage of spermatozoa with regular morphology. These results demonstrate that treatment with FSH is effective in patients with idiopathic OAT and that there are no significant differences between the different preparations. The novelty of this study is in the significant reduction of the concentration of CD45pos cells observed after the treatment.
机译:本研究评估了不育患者特发性少脂少肌精子症(OAT)的常规精子参数和CD45pos细胞(全白细胞标志物)的精液浓度。将患者任意分为三组,分别用重组促卵泡激素FSH治疗:α(A组= 20例),重组FSH-β(B组= 20例)和高纯度人FSH(C组= 14例)。 。所有治疗组的主要精子参数(密度,进行性运动和形态)均获得了类似的改善,但是在所有三个检查组中,只有形态正常的精子百分比的增加才显着。此外,所有组的CD45pos细胞精液浓度和未成熟生殖细胞百分比均显着降低。在治疗前后,CD45pos细胞的浓度与未成熟生殖细胞的百分比呈线性正相关,与形态规则的精子的百分比呈负相关。这些结果表明,FSH治疗对特发性OAT患者有效,并且不同制剂之间无显着差异。这项研究的新颖之处在于治疗后观察到的CD45pos细胞浓度显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号